Jee H. Ahn

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Correction: Lee et al. Discrepancies Between the Tennessee Nomogram and Oncotype DX: Implications for the Korean Breast Cancer Population-The BRAIN Study. Cancers 2025, 17, 3083.

Correction: Lee et al. Discrepancies Between the Tennessee Nomogram and Oncotype DX: Implications for the Korean Breast Cancer Population-The BRAIN Study. Cancers 2025, 17, 3083.

Journal: Cancers
Published: December 08, 2025

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Journal: Molecular therapy. Oncology
Published: November 05, 2025

Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer.

Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer.

Journal: Clinical breast cancer
Published: August 23, 2025

Discrepancies Between the Tennessee Nomogram and Oncotype DX: Implications for the Korean Breast Cancer Population-The BRAIN Study.

Discrepancies Between the Tennessee Nomogram and Oncotype DX: Implications for the Korean Breast Cancer Population-The BRAIN Study.

Journal: Cancers
Published: August 04, 2025

Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25).

Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25).

Journal: Journal of breast cancer
Published: August 01, 2025

Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.

Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.

Journal: Journal of breast cancer
Published: July 23, 2025

A Randomized Trial of Sentinel Node Biopsy Omission After Neoadjuvant Systemic Therapy in Clinically Node-Negative or Selected Node-Positive Breast Cancer.

A Randomized Trial of Sentinel Node Biopsy Omission After Neoadjuvant Systemic Therapy in Clinically Node-Negative or Selected Node-Positive Breast Cancer.

Journal: Journal of breast cancer
Published: June 30, 2025

Long-term survival outcomes of male breast cancer: the propensity score matching analysis of nationwide registry database.

Long-term survival outcomes of male breast cancer: the propensity score matching analysis of nationwide registry database.

Journal: Breast (Edinburgh, Scotland)
Published: February 25, 2025

Impact of Axillary Burden on Survival: A Comparative Study of Invasive Lobular Carcinoma and Invasive Ductal Carcinoma in Early-Stage Breast Cancer.

Impact of Axillary Burden on Survival: A Comparative Study of Invasive Lobular Carcinoma and Invasive Ductal Carcinoma in Early-Stage Breast Cancer.

Journal: Cancers
Published: January 30, 2025

Characteristics of premenopausal breast cancer patients with a midrange 21-gene recurrence score.

Characteristics of premenopausal breast cancer patients with a midrange 21-gene recurrence score.

Journal: Annals of surgical treatment and research
Published: December 04, 2024

Long-term Outcomes of Early Breast Cancer Stratified by Axillary Ultrasound Assessment.

Long-term Outcomes of Early Breast Cancer Stratified by Axillary Ultrasound Assessment.

Journal: Journal of breast cancer
Published: October 30, 2024

Clinical Usefulness of a Multigene Testing in Patients with Special Histologic Type Breast Cancer.

Clinical Usefulness of a Multigene Testing in Patients with Special Histologic Type Breast Cancer.

Journal: Yonsei medical journal
Published: October 12, 2024
Showing 1-12 of 23

Last Updated: 09/26/2026